[{"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0037-2023", "product_description": "MEDROXYPROGESTERONE ACETATE 300 MG/ML Suspension, 10 mL vial, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "40 vials", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lot: 55786, BUD: 12/31/2022"}, {"status": "Terminated", "city": "Westborough", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91243", "recalling_firm": "Atlantic Management Resources Ltd.", "address_1": "39 Harvey Ln", "address_2": "N/A", "postal_code": "01581-3013", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide and Australia", "recall_number": "D-0083-2023", "product_description": "ProSirona, A Homeopathic Formula, Calendula Oil packaged in 1/8 Fl. oz. (3.5 g) bottles, Dist. by: Endometriosis Assoc. Inc. (International), Mfg. by Claire Ellen Topicals, P.O. Box 901 Westborough, MA 01581, USA, NDC# 66233-712-01.", "product_quantity": "72 bottles", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20221212", "center_classification_date": "20221213", "termination_date": "20230920", "report_date": "20221221", "code_info": "Lot Code B-02"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0040-2023", "product_description": "MOXIFLOXACIN PRESERVATIVE FREE SYR, 0.15 mg/0.1 mL, Sterile Solution, 1 mL syringes, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "106 syringes", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lot: 66470, BUD: 11/10/2022"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA209735"], "brand_name": ["ESOMEPRAZOLE MAGNESIUM"], "generic_name": ["ESOMEPRAZOLE MAGNESIUM"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc"], "product_ndc": ["63304-734", "63304-735"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ESOMEPRAZOLE MAGNESIUM"], "rxcui": ["606726", "606730"], "spl_id": ["6d8e57e7-6cc5-4edc-8a4e-47ab7fdae397"], "spl_set_id": ["dc85d0c8-d3c4-4d37-9a5b-8f5f992bb3bf"], "package_ndc": ["63304-734-90", "63304-734-30", "63304-734-10", "63304-735-90", "63304-735-30", "63304-735-10"], "is_original_packager": [true], "upc": ["0363304734300", "0363304734904", "0363304735307"], "unii": ["R6DXU4WAY9"]}, "product_type": "Drugs", "event_id": "90891", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0004-2023", "product_description": "Esomeprazole Magnesium Delayed-Release Capsules, USP 20mg, Rx Only, 90 Capsules per bottle, Manufactured by: Ohm Laboratories Inc. New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 63304-734-90.", "product_quantity": "5712 bottles", "reason_for_recall": "Superpotent Drug: Out of specification for assay at the 12-month timepoint.", "recall_initiation_date": "20220621", "center_classification_date": "20221006", "termination_date": "20230811", "report_date": "20221005", "code_info": "Lot AC14299, Exp 12/2022"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0047-2023", "product_description": "PAPAVERINE HCL STOCK SOLUTION 30MG/ML SOLUTION, 10 mL vial, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "28 vials", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lot: 60552, BUD: 03/12/2023"}, {"status": "Terminated", "city": "Fayetteville", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91229", "recalling_firm": "OurPharma LLC", "address_1": "2512 S City Lake Rd", "address_2": "N/A", "postal_code": "72701-5013", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MO", "recall_number": "D-0078-2023", "product_description": "FentaNYL Citrate 2.5 mg/50 mL (50mcg/ml) Injection Solution, Preservative Free, Single Use 50 ml Cassette, Rx Only, Repackaged by OurPharma, LLC. 2512 S. City Lake Rd. Fayetteville, AR 72701, 1-833-290-2654, NDC 73013-001-01", "product_quantity": "691 cassettes", "reason_for_recall": "Underfilled units.", "recall_initiation_date": "20221129", "center_classification_date": "20221209", "termination_date": "20240920", "report_date": "20221221", "code_info": "Lots: 100122060007 Exp. 12/17/2022; 100122060008 Exp. 12/18/2022; 100122070002 Exp. 01/09/2023."}, {"status": "Terminated", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90886", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "N/A", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1542-2022", "product_description": "Ampicillin for Injection, USP, 2 grams/vial NDC 67457-352-02, packaged in 10 x 2 g vials per carton NDC 67457-352-10, Rx only, Mylan Manufactured in India for: Mylan Institutional LLC Rockford, IL 61103 U.S.A", "product_quantity": "3,931 cartons", "reason_for_recall": "Presence of Particulate Matter: A complaint was received for the presence of a single strand of hair in one vial.", "recall_initiation_date": "20220921", "center_classification_date": "20220923", "termination_date": "20231031", "report_date": "20221005", "code_info": "Lot 7105130, exp 9/2023"}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206918"], "brand_name": ["FONDAPARINUX SODIUM"], "generic_name": ["FONDAPARINUX SODIUM"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-230", "55150-231", "55150-232", "55150-233"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["FONDAPARINUX SODIUM"], "rxcui": ["861356", "861360", "861363", "861365"], "spl_id": ["a193830a-dc25-412a-b047-d2fa77d9dbbc"], "spl_set_id": ["8ea61d0d-4403-4d9f-a946-85a459cc0aa0"], "package_ndc": ["55150-230-00", "55150-230-02", "55150-230-10", "55150-231-00", "55150-231-02", "55150-231-10", "55150-232-00", "55150-232-02", "55150-232-10", "55150-233-00", "55150-233-02", "55150-233-10"], "is_original_packager": [true], "unii": ["X0Q6N9USOZ"]}, "product_type": "Drugs", "event_id": "90925", "recalling_firm": "AuroMedics Pharma LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0020-2023", "product_description": "Fondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Single Dose, Prefilled Syringe, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520. Made in India. NDC 55150-232-10 (carton)NDC 55150-232-00 (syringe)", "product_quantity": "11,520 units", "reason_for_recall": "Subpotent Drug: Out of specification for assay", "recall_initiation_date": "20220930", "center_classification_date": "20221024", "termination_date": "20240918", "report_date": "20221102", "code_info": "Lot # CFN200020, EXP Nov. 2022", "more_code_info": ""}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0033-2023", "product_description": "GLYCERIN OPHTHALMIC DROPS 98.5% Solution, 10 mL droptainer, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "1 droptainer", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lot: 65416, BUD: 10/13/2022"}, {"status": "Terminated", "city": "Alpharetta", "state": "GA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "91150", "recalling_firm": "Acella Pharmaceuticals, LLC", "address_1": "1880 Mcfarland Pkwy Ste 110", "address_2": "", "postal_code": "30005-1795", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0074-2023", "product_description": "Sodium Sulfacetamide 10% Sulfur 4% Cleansing Pads, Net weight 3.7g (60 cleansing pads Net weight 3.7 g each per carton,) Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 300025, NDC 42192-113-60", "product_quantity": "528 cartons", "reason_for_recall": "Subpotent drug: Out of specification for assay at the end-of-shelf-life 24-month period.", "recall_initiation_date": "20221114", "center_classification_date": "20221201", "termination_date": "20240801", "report_date": "20221207", "code_info": "Lot#: 21084, 21085, Exp 06/30/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Piscataway", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA209301"], "brand_name": ["LACOSAMIDE"], "generic_name": ["LACOSAMIDE"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "product_ndc": ["31722-627"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LACOSAMIDE"], "spl_id": ["3feb1c1a-c299-1862-e063-6394a90af07e"], "spl_set_id": ["bbd80370-3d23-41f8-8914-c6ea897c0154"], "package_ndc": ["31722-627-26", "31722-627-46"], "is_original_packager": [true], "upc": ["0331722627269", "0331722627467"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["563KS2PQY5"]}, "product_type": "Drugs", "event_id": "91239", "recalling_firm": "Camber Pharmaceuticals, Inc", "address_1": "1031 Centennial Ave", "address_2": "N/A", "postal_code": "08854-4125", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0094-2023", "product_description": "Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Manufactured By: HETERO LABS LIMITED, Jeedimetla, Hyderabad - 500 055, India, NDC 31722-627-26", "product_quantity": "N/A", "reason_for_recall": "Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content", "recall_initiation_date": "20221206", "center_classification_date": "20221228", "termination_date": "20240315", "report_date": "20221221", "code_info": "Lot#: E222200, E222199, Exp 05/2024; E222228, Exp 06/2024"}, {"status": "Terminated", "city": "Bloomsbury", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "90898", "recalling_firm": "QuVa Pharma, Inc.", "address_1": "519 State Route 173", "address_2": "N/A", "postal_code": "08804-4047", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1544-2022", "product_description": "oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride, Injection for IV Use, High Alert, This is a Compounded Product for Institutional or Office Use Only, Not for Resale, QuVa PHARMA 519 Route 173, Bloomsbury, NJ 08804, Total volume: 500 mL bag, NDC: 70092-1068-07.", "product_quantity": "1994 bags", "reason_for_recall": "Incorrect Product Formulation: Oxytocin 30 units was added to an IV bag of 0.45% Sodium Chloride (500mL) instead of 0.9% Sodium Chloride (500mL).", "recall_initiation_date": "20220920", "center_classification_date": "20220926", "termination_date": "20230208", "report_date": "20221005", "code_info": "Lot 30027403, BUD 11/14/2022"}, {"status": "Terminated", "city": "Chennai", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91110", "recalling_firm": "Par Formulations Private Limited", "address_1": "9/215 Pudupakkam-Vandalur Main Road", "address_2": "Pudupakkam, Kelambakkam", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0061-2023", "product_description": "Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottles, RX only Dist. by: Par Pharmaceutical Chestnut Ridge, NY 10977 U.S.A. Mfg. by: Par Forumulations Private Limited,9/215, Pudupakkam, Kelambakkam - 603 103. NDC 49884-038-01", "product_quantity": "218 bottles/100 capsules per bottle", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20221110", "center_classification_date": "20221115", "termination_date": "20230818", "report_date": "20221123", "code_info": "Lot #: 15429401, Exp. Date 08/2023"}, {"status": "Terminated", "city": "South San Francisco", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["BLA761197"], "brand_name": ["SUSVIMO"], "generic_name": ["RANIBIZUMAB"], "manufacturer_name": ["Genentech, Inc."], "product_ndc": ["50242-078"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVITREAL"], "substance_name": ["RANIBIZUMAB"], "rxcui": ["2584857", "2584863"], "spl_id": ["2ffa1867-28d5-460f-b4ab-f9c837aa27ec"], "spl_set_id": ["9c6d9e2a-9a77-4d11-b692-de87cfde3444"], "package_ndc": ["50242-078-12", "50242-078-55", "8100425900", "0081004259"], "is_original_packager": [true], "nui": ["N0000193542", "N0000193543"], "pharm_class_moa": ["Vascular Endothelial Growth Factor Inhibitors [MoA]"], "pharm_class_epc": ["Vascular Endothelial Growth Factor Inhibitor [EPC]"], "unii": ["ZL1R02VT79"]}, "product_type": "Drugs", "event_id": "90959", "recalling_firm": "Genentech Inc", "address_1": "1 Dna Way", "address_2": "N/A", "postal_code": "94080-4918", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0025-2023", "product_description": "Susvimo (ranibizumab injection), 100mg/mL, sold together as a) carton containing One Susvimo single-dose vial and One Susvimo initial fill needle, NDC 50242-078-55; and b) carton labeled as Susvimo Ocular Implant with Insertion Tool Assembly, containing One carrier with implant and One insertion Tool, UDI 81004259001, GTIN 00810042590014, Rx only, Genentech, Inc., A Member of the Roche Group, South San Francisco, CA  94080-4990.", "product_quantity": "452 vials and implants", "reason_for_recall": "Defective Delivery System: Commercial implants do not meet the filed specification for the intended use, a few patients have experienced an issue with the implants that renders it non-functioning.", "recall_initiation_date": "20221018", "center_classification_date": "20221101", "termination_date": "20240417", "report_date": "20221109", "code_info": "Lot/Exp: a) 3499188, Exp 10/31/2022; Lot 3523071, Exp 6/30/2023; b) 3456735, Exp 10/23/2026; 3456737; Exp 10/29/2026; 3477671, Exp 10/31/2026; 3480781, Exp 12/19/2026; 3506526, Exp 02/25/2027; 3506531, Exp 04/15/2027"}, {"status": "Terminated", "city": "Lenoir", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA211091"], "brand_name": ["SODIUM BICARBONATE"], "generic_name": ["SODIUM BICARBONATE"], "manufacturer_name": ["Civica"], "product_ndc": ["72572-740"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM BICARBONATE"], "rxcui": ["1868486"], "spl_id": ["98efb401-5361-41ff-979a-6857768a144c"], "spl_set_id": ["a10fdfbc-94a0-49ab-b26c-de1df042bc89"], "package_ndc": ["72572-740-20", "72572-740-25"], "is_original_packager": [true], "upc": ["0372572740258"], "unii": ["8MDF5V39QO"]}, "product_type": "Drugs", "event_id": "91197", "recalling_firm": "Exela Pharma Sciences LLC", "address_1": "1245 Blowing Rock Blvd", "address_2": "N/A", "postal_code": "28645-3618", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0080-2023", "product_description": "8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx Only, Mfd for: Civica, Inc. Lehi, Utah 84043, Mfd by: Exela Pharma Sciences, LLC, Lenoir, NC 28645, Carton NDC 72572-740-20, vial NDC 72572-740-1.", "product_quantity": "37,320 vials", "reason_for_recall": "Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.", "recall_initiation_date": "20221128", "center_classification_date": "20221213", "termination_date": "20251010", "report_date": "20221221", "code_info": "Lot: P0001490 Exp. 12/2023"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0026-2023", "product_description": "ACETYLCYSTEINE OPTH 10% Solution, 15 mL droptainers, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "1 droptainer", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lot: 66895, BUD: 11/19/2022"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA209735"], "brand_name": ["ESOMEPRAZOLE MAGNESIUM"], "generic_name": ["ESOMEPRAZOLE MAGNESIUM"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc"], "product_ndc": ["63304-734", "63304-735"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ESOMEPRAZOLE MAGNESIUM"], "rxcui": ["606726", "606730"], "spl_id": ["6d8e57e7-6cc5-4edc-8a4e-47ab7fdae397"], "spl_set_id": ["dc85d0c8-d3c4-4d37-9a5b-8f5f992bb3bf"], "package_ndc": ["63304-734-90", "63304-734-30", "63304-734-10", "63304-735-90", "63304-735-30", "63304-735-10"], "is_original_packager": [true], "upc": ["0363304734300", "0363304734904", "0363304735307"], "unii": ["R6DXU4WAY9"]}, "product_type": "Drugs", "event_id": "90891", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0005-2023", "product_description": "Esomeprazole Magnesium Delayed-Release Capsules, USP, 40mg, Rx Only, 90 Capsules per bottle, Manufactured by: Ohm Laboratories Inc. New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 63304-735-90.", "product_quantity": "8640 bottles", "reason_for_recall": "Superpotent Drug: Out of specification for assay at the 12-month timepoint.", "recall_initiation_date": "20220621", "center_classification_date": "20221006", "termination_date": "20230811", "report_date": "20221005", "code_info": "Lot AC14304, Exp 12/2022."}, {"status": "Terminated", "city": "Ontario", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90973", "recalling_firm": "Ultra Chem Labs Corp", "address_1": "4581 Brickell Privado St", "address_2": "N/A", "postal_code": "91761-7828", "voluntary_mandated": "N/A", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0017-2023", "product_description": "Proton Armor, Anti-Microbial Alcohol-Free Foaming Hand Sanitizer, kills 99.99% of germs, Green Tea and Aloe, Family Safe, No Gels, Water Based, 24 Hour Germ Protection with Moisturizers for Sensitive Skin, a) 8 oz bottle, b) 32 oz bottle, and c) 1.7 fl oz or 50 mL bottle, Supplier details: Ultra Chem Labs, Ontario, CA, Active Ingredients - Benzalkonium Chloride 0.13% (antimicrobial), ULS 8357 0.33% (antimicrobial shield), NDC 79208-001-50.", "product_quantity": "5-10 gallons", "reason_for_recall": "Chemical Contamination and CGMP Deviations: trace amounts of methanol found in one of the components during the manufacturing process.", "recall_initiation_date": "20220815", "center_classification_date": "20221021", "termination_date": "20240813", "report_date": "20221102", "code_info": "Batch 20117206. No Expiration dates Product Code: a) 3030-8 (8 oz) b) 3030-3 (32 oz) c) 3030-5 (1.7 fl oz./50 mL)", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077690"], "brand_name": ["QUINAPRIL"], "generic_name": ["QUINAPRIL"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-554", "68180-556", "68180-557", "68180-558", "68180-559"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["QUINAPRIL HYDROCHLORIDE"], "rxcui": ["312748", "312749", "312750", "314203"], "spl_id": ["a9598a21-6f99-4c86-ace6-b5638da2bec8"], "spl_set_id": ["8ded0773-3aec-4e89-9836-d22a5a84abf0"], "package_ndc": ["68180-556-09", "68180-557-09", "68180-557-03", "68180-558-09", "68180-558-03", "68180-554-09", "68180-554-03", "68180-559-03", "68180-559-09"], "is_original_packager": [true], "upc": ["0368180559092", "0368180556091"], "unii": ["33067B3N2M"]}, "product_type": "Drugs", "event_id": "91279", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed by major distribution chains nationwide.", "recall_number": "D-0089-2023", "product_description": "Quinapril Tablets USP, 20 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, by: Lupin Limited, Goa 403 722 India, NDC# 68180-558-09", "product_quantity": "23,736", "reason_for_recall": "CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.", "recall_initiation_date": "20221207", "center_classification_date": "20221223", "termination_date": "20240801", "report_date": "20221228", "code_info": "Lot #: G102929, Exp 04/2023", "more_code_info": ""}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207880"], "brand_name": ["DESMOPRESSIN ACETATE"], "generic_name": ["DESMOPRESSIN ACETATE"], "manufacturer_name": ["Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc."], "product_ndc": ["23155-489", "23155-490"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DESMOPRESSIN ACETATE"], "rxcui": ["833008", "849515"], "spl_id": ["3ed8c1cf-5b26-49fc-adb2-264572e68cbe"], "spl_set_id": ["e87b6cfd-5677-4398-883d-7ced5dd678ef"], "package_ndc": ["23155-489-01", "23155-489-05", "23155-490-01", "23155-490-05"], "is_original_packager": [true], "unii": ["XB13HYU18U"]}, "product_type": "Drugs", "event_id": "91171", "recalling_firm": "Heritage Pharmaceuticals Inc", "address_1": "1 Tower Center Blvd Ste 1700", "address_2": "", "postal_code": "08816-1145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0072-2023", "product_description": "Desmopressin Acetate Tablets 0.2mg, 100-count bottles, RX Only, Distributed by: Avet Pharmaceuticals Inc. East Brunswick, NJ 08816, NDC 23155-490-01", "product_quantity": "13805 Bottles each containing 100 tablets", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20221123", "center_classification_date": "20221129", "termination_date": "20231213", "report_date": "20221207", "code_info": "Lot #: 220440A, Exp. Date 05/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0043-2023", "product_description": "PAPAVERINE / PHENTOLAMINE / PROSTAGLANDIN INJ 150MG/10MG/100MCG/ BOTTLE SOLUTION, 5 ML vial, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lot: 66576, BUD: 11/09/2022"}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA205035"], "brand_name": ["TRANEXAMIC ACID"], "generic_name": ["TRANEXAMIC ACID"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-188"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["TRANEXAMIC ACID"], "spl_id": ["e8b14a77-9700-431c-a699-8a0984cc5c21"], "spl_set_id": ["246a3c6c-a7fb-45c7-9509-49a48a5bdcc6"], "package_ndc": ["55150-188-10"], "is_original_packager": [true], "upc": ["0355150188109"], "nui": ["N0000175634", "N0000175632"], "pharm_class_epc": ["Antifibrinolytic Agent [EPC]"], "pharm_class_pe": ["Decreased Fibrinolysis [PE]"], "unii": ["6T84R30KC1"]}, "product_type": "Drugs", "event_id": "90897", "recalling_firm": "AuroMedics Pharma LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1551-2022", "product_description": "Tranexamic Acid Injection, USP, 1000mg per 10 mL (100mg /mL), 10mL single-dose vial, Rx Only, Distributed by: AuroMedics Pharma LLC E. Windsor, NJ 08520, Made in India, NDC 55150-188-10", "product_quantity": "88080 vials", "reason_for_recall": "Presence of Particulate Matter: Piece of metal found in a vial", "recall_initiation_date": "20220926", "center_classification_date": "20220930", "report_date": "20221012", "code_info": "Lot: CTA210006, Exp. 02/2024"}, {"status": "Terminated", "city": "Alpharetta", "state": "GA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA040573"], "brand_name": ["PHENYTOIN SODIUM"], "generic_name": ["PHENYTOIN SODIUM"], "manufacturer_name": ["Acella Pharmaceuticals, LLC"], "product_ndc": ["42192-614"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["PHENYTOIN SODIUM"], "rxcui": ["1670351", "1670353"], "spl_id": ["ae14cce7-f65a-45e0-8ff4-9388d0a806d2"], "spl_set_id": ["6922f32f-8bed-4c09-8103-27987bcbd104"], "package_ndc": ["42192-614-10", "42192-614-30", "42192-614-05"], "is_original_packager": [true], "unii": ["4182431BJH"]}, "product_type": "Drugs", "event_id": "91149", "recalling_firm": "Acella Pharmaceuticals, LLC", "address_1": "1880 Mcfarland Pkwy Ste 110", "address_2": "N/A", "postal_code": "30005-1795", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0070-2023", "product_description": "Phenytoin Sodium Injection, USP, 250 mg/5 mL, NDC 42192-614-05, packaged in 10 x 5 mL vials per carton, NDC 42192-614-30, Rx only, Manufactured for: Acella Pharmaceuticals, LLC Alpharetta, GA 30005", "product_quantity": "637 cartons", "reason_for_recall": "Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.", "recall_initiation_date": "20221114", "center_classification_date": "20221123", "termination_date": "20240821", "report_date": "20221130", "code_info": "Lot: E026A001 Exp. 06/2023"}, {"status": "Terminated", "city": "Ledgewood", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91140", "recalling_firm": "ImprimisRx NJ", "address_1": "1705 Us Highway 46 Ste 4", "address_2": "N/A", "postal_code": "07852-9720", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0060-2023", "product_description": "Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.", "product_quantity": "960 bottles", "reason_for_recall": "Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.", "recall_initiation_date": "20221109", "center_classification_date": "20221114", "termination_date": "20230823", "report_date": "20221123", "code_info": "Lot # 06272022@3, Exp. date 11/24/2022 Lot # 08302022@1, Exp. date 01/27/2023"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "91190", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0073-2023", "product_description": "Allergy Relief D, Fexofenadine HCL 60mg/Antihistamine, Pseudoephedrine HCL 120mg/Nasal Decongestant, Extended-Release Tablets USP, packaged as (a) 20 count carton NDC 49032-273-20; (b) 30 count carton, NDC49032-273-30; Distributed by: Walmart Inc., Bentonville, AR 72716, Product of India", "product_quantity": "25,176, 30-count; 22,968 20-count", "reason_for_recall": "Failed dissolution specifications", "recall_initiation_date": "20221121", "center_classification_date": "20221130", "termination_date": "20240828", "report_date": "20221207", "code_info": "Lot# (a) AC2203133B,  EXP 01/2024; (b) AC2203133A,  EXP 01/2024.", "more_code_info": ""}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0055-2023", "product_description": "TALC, STERILE POWDER, 5 GM vial, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lot: 65995, BUD: 10/28/2022"}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91132", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0065-2023", "product_description": "PF-Neostigmine Methylsulfate Injection, USP 3 mg/3 mL (1 mg/mL) vial, Rx Only, Nephron 503B Outsourcing Facility 4500 12th Street Extension West Columbia, SC 29172, NDC 69374-932-33, UPC 3 69374-93233 2.", "product_quantity": "56,220 vials", "reason_for_recall": "CGMP Deviations: Potential for cross contamination due to product carry over.", "recall_initiation_date": "20221110", "center_classification_date": "20221117", "termination_date": "20240924", "report_date": "20221123", "code_info": "Lots: NE1062A, NE1062B Exp. 12/02/2022; NE1065A, NE1065B Exp. 12/13/2022; NE2011A, NE2011B Exp. 03/15/2022."}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90880", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide and Puerto Rico", "recall_number": "D-1547-2022", "product_description": "Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Distributed by: Akorn Operating Company, LLC, Gurnee, IL 60031,  NDC 61748-015-30", "product_quantity": "18,145 bottles", "reason_for_recall": "Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).", "recall_initiation_date": "20220921", "center_classification_date": "20220928", "report_date": "20221005", "code_info": "Lot#: 3192818, Exp 10/31/2022; 3199700, Exp 03/31/2023; 3203853, Exp 02/29/2024"}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "90874", "recalling_firm": "Salon Technologies International Inc", "address_1": "8810 Commodity Cir Ste 20", "address_2": "N/A", "postal_code": "32819-9066", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL and WA only", "recall_number": "D-0002-2023", "product_description": "Antica Farmacista Hand Sanitizer Ocean Citron (ethyl alcohol, denatured 65%) packaged in 473 mL/16 fl. oz. bottles,  Dist. By Antica Farmacista Seattle, WA 98122 UPC 8 47005 00450 9", "product_quantity": "512 bottles", "reason_for_recall": "Chemical Contamination: product found to contain benzene", "recall_initiation_date": "20220914", "center_classification_date": "20221004", "termination_date": "20240820", "report_date": "20221012", "code_info": "Lot #: 1166A Exp. 6/18/2023"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0046-2023", "product_description": "PAPAVERINE / PHENTOLAMINE INJECTION 150MG / 5MG / VIAL SOLUTION, 10 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "242 vials", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lots: 55092, BUD: 10/22/2022; 59100, BUD: 10/30/2022; 62038, BUD: 04/08/2023; 66533, BUD: 04/08/2023"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0050-2023", "product_description": "PHENTOLAMINE 10MG/ML INJECTION, 10MG/ML SOLUTION, 10 mL vial, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "10 vials", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lots: 60586, BUD: 11/01/2022; 64203, BUD: 01/28/2023"}, {"status": "Ongoing", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078177"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Fresenius Medical Care North America"], "product_ndc": ["49230-300"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807639"], "spl_id": ["26587576-d68d-4c98-e063-6394a90ac53d"], "spl_set_id": ["af5cdf1a-19f4-11e2-892e-0800200c9a66"], "package_ndc": ["49230-300-10"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "91226", "recalling_firm": "Fresenius Medical Care Holdings, Inc.", "address_1": "920 Winter St Bld 950", "address_2": "N/A", "postal_code": "02451-1521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed Nationwide in the USA.", "recall_number": "D-0075-2023", "product_description": "0.9% Sodium Chloride Injection, USP, Each 100 mL contains: SODIUM CHLORIDE, USP - 900 mg, WATER FOR INJECTION, USP - qs, 1000mL Bag, 12 PK, Rx Only, Fresenius Medical Care North America, Waltham, MA 02451, NDC 49230-300-10", "product_quantity": "4,097 cases/12 bags per case", "reason_for_recall": "Lack of Assurance of Sterility: Leakage of 0.9% Sodium Chloride for Injection, 1L, 12pk Saline Solution.", "recall_initiation_date": "20221122", "center_classification_date": "20221202", "report_date": "20221214", "code_info": "Lot # 22HU05062, 22HU06059, 22HU05035, EXP 06/30/2023; 22JU05001, EXP 07/31/2023"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0034-2023", "product_description": "LAURETH-9 INJ 2% Solution, 30 ML vial, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "3 vials", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lot: 66513, BUD: 11/10/2022"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0049-2023", "product_description": "PAPAVERINE/PHENTOLAMINE/PROSTAGLANDIN INJ 150MG/5MG/10MCG/VIAL SOLUTION, 5 ML vial, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lot: 65976, BUD: 10/27/2022"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0051-2023", "product_description": "PRED ACETATE / GATIFLOXACIN 1% / 0.5% SUSP, 10 mL droptainers, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "378 droptainers", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lots: 65056, BUD: 11/18/2022; 66246, BUD: 11/19/2022"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0031-2023", "product_description": "CEFUROXIME INTRAVITREAL SYR 1MG/0.1ML Solution in 1 mL syringe, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "460 syringes", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lots: 63265, BUD: 01/24/2023; 66085, BUD: 04/03/2023"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0038-2023", "product_description": "METHYLCOBALAMIN PF 1 ML Injection Solution 5,000 MCG/ML Solution, 1 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "514 vials", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lot: 57997, BUD: 02/25/2023; 64941, BUD: 03/08/2023"}, {"status": "Terminated", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207306"], "brand_name": ["ARFORMOTEROL TARTRATE"], "generic_name": ["ARFORMOTEROL TARTRATE"], "manufacturer_name": ["Cipla USA Inc."], "product_ndc": ["69097-168"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["ARFORMOTEROL TARTRATE"], "rxcui": ["668956"], "spl_id": ["07b162cc-b71c-4750-a10b-2db80625012f"], "spl_set_id": ["70071afd-5323-4019-aca5-5534278829dc"], "package_ndc": ["69097-168-48", "69097-168-87", "69097-168-64", "69097-168-32", "69097-168-53"], "is_original_packager": [true], "unii": ["5P8VJ2I235"]}, "product_type": "Drugs", "event_id": "90920", "recalling_firm": "CIPLA", "address_1": "10 Independence Blvd", "address_2": "N/A", "postal_code": "07059-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide to distributors/wholesalers who may have further distributed the product.", "recall_number": "D-1550-2022", "product_description": "Arformoterol Tartrate Inhalation Solution, 15 mcg/2mL, 2 mL Sterile Unit-Dose Vial packaged in 5 x 2 mL Sterile Unit-Dose Vials per pouch, NDC 69097-168-48; 60 (12 x 5) x 2 mL Sterile Unit-Dose Vials per carton, NDC 69097-168-64, Rx Only, Manufactured by: Cipla Ltd., Indore SEZ, Pithampur, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ  07059.", "product_quantity": "9041 cartons", "reason_for_recall": "Lack of Assurance of Sterility: environmental monitoring failure.", "recall_initiation_date": "20220929", "center_classification_date": "20220930", "termination_date": "20230725", "report_date": "20221012", "code_info": "Batch No: IA10082, IA10083, IA10084, IA10085, IA10086, exp. date 01/2023; IA10122, IA10123, IA10124, IA10125, IA10126, IA10127, IA10128, IA10129, IA10130, exp. date 02/2023"}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90874", "recalling_firm": "Salon Technologies International Inc", "address_1": "8810 Commodity Cir Ste 20", "address_2": "N/A", "postal_code": "32819-9066", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL and WA only", "recall_number": "D-0001-2023", "product_description": "Sanitizing Hand Spray 80% (alcohol 80% v/v) Packaged in 2 FL OZ (60 mL) bottles, Salon Technologies International 8810 Commodity Circle STE 22-23, Orlando, FL 32819, UPC 6 96952 12904 5", "product_quantity": "1656 bottles", "reason_for_recall": "GMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.", "recall_initiation_date": "20220914", "center_classification_date": "20221004", "termination_date": "20240820", "report_date": "20221012", "code_info": "Lot #: 20-018 Exp. 4/3/2023"}, {"status": "Terminated", "city": "Arlington", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90828", "recalling_firm": "Justified Laboratories", "address_1": "2131 N Collins St", "address_2": "Ste 433-732", "postal_code": "76011-2849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0008-2023", "product_description": "Skincell Mole & Skin Corrector Serum, 1 fl. oz./30 mL jars,  Distributed By: Justified Laboratoires, Arlington, TX 76011 USA UPC 8 10077 53220 1", "product_quantity": "Unknown", "reason_for_recall": "Marketed Without An Approved NDA/ANDA; Unapproved new drug", "recall_initiation_date": "20220909", "center_classification_date": "20221007", "termination_date": "20230810", "report_date": "20221019", "code_info": "All lots remaining within expiry."}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0054-2023", "product_description": "SERUM TEARS IN NSAL 20% OPTH SOLUTION, 3 mL droptainers, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "45 droptainers", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lots: 65490, BUD: 10/14/2022; 65584, BUD: 10/16/2022; 66013, BUD: 10/28/2022"}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211694"], "brand_name": ["PYRIDOSTIGMINE BROMIDE"], "generic_name": ["PYRIDOSTIGMINE BROMIDE"], "manufacturer_name": ["VistaPharm, LLC"], "product_ndc": ["66689-406"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PYRIDOSTIGMINE BROMIDE"], "rxcui": ["903843"], "spl_id": ["b6373af3-7b5a-4eb5-b080-e0a81975f6c4"], "spl_set_id": ["9ab2ece0-7c0d-4045-a9f1-447aa97d623e"], "package_ndc": ["66689-406-01", "66689-406-10"], "original_packager_product_ndc": ["70954-148"], "unii": ["KVI301NA53"]}, "product_type": "Drugs", "event_id": "90943", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "N/A", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0018-2023", "product_description": "Pyridostigmine Bromide Oral Solution, USP 60 mg/5 mL Delivers 5 mL, packaged in 5mL unit-dose cup, Rx only, Dist. by: VistaPharm, NDC 66689-406-01", "product_quantity": "1980 cups", "reason_for_recall": "cGMP Deviations: Out of specification for assay of one of the preservative ingredients.", "recall_initiation_date": "20220930", "center_classification_date": "20221021", "termination_date": "20240430", "report_date": "20221102", "code_info": "Lot#:  832400, Exp 08/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA073457"], "brand_name": ["ATENOLOL"], "generic_name": ["ATENOLOL"], "manufacturer_name": ["Golden State Medical Supply, Inc."], "product_ndc": ["60429-025", "60429-027", "60429-026"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATENOLOL"], "rxcui": ["197379", "197380", "197381"], "spl_id": ["1f3336f5-1448-aa4e-e063-6394a90a7464"], "spl_set_id": ["f4f06c00-9024-4e04-a882-0da2b24d8ff7"], "package_ndc": ["60429-027-90", "60429-027-10", "60429-025-90", "60429-025-10", "60429-026-90", "60429-026-10"], "original_packager_product_ndc": ["0378-0218", "0378-0231", "0378-0757"], "nui": ["N0000000161", "N0000175556"], "pharm_class_moa": ["Adrenergic beta-Antagonists [MoA]"], "pharm_class_epc": ["beta-Adrenergic Blocker [EPC]"], "unii": ["50VV3VW0TI"]}, "product_type": "Drugs", "event_id": "90909", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "N/A", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0019-2023", "product_description": "Atenolol Tablets, USP, 25 mg, 1000-count bottle, Rx only, Manufactured by: ALPHAPHARM PTY LTD, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC 60429-027-10", "product_quantity": "2,584 Bottles", "reason_for_recall": "Label Mix - up; a bottle labeled as Atenolol 25mg Tablets contained Clopidogrel 75mg Tablets", "recall_initiation_date": "20220929", "center_classification_date": "20221021", "termination_date": "20250320", "report_date": "20221102", "code_info": "Lot #: GS046745, Exp 12/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019635"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["B. Braun Medical Inc."], "product_ndc": ["0264-5802", "0264-5804"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807552", "1807634", "1807639"], "spl_id": ["d34ea9bc-a1f9-402a-97cf-894505cee75d"], "spl_set_id": ["e44c41ae-c9c8-4dd8-ba6c-cebb585378aa"], "package_ndc": ["0264-5802-00", "0264-5802-10", "0264-5804-00", "0061832446"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "91194", "recalling_firm": "B. Braun Medical, Inc.", "address_1": "901 Marcon Blvd", "address_2": "N/A", "postal_code": "18109-9512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, NJ, PA", "recall_number": "D-0076-2023", "product_description": "0.9% Sodium Chloride Injection USP 1000 mL Single-dose container Rx only NDC 0264-5802-00 B. Braun Medical Inc. Bethlehem, PA 18018-3524 USA 1-800-227-2862", "product_quantity": "756 bags", "reason_for_recall": "Lack of sterility assurance: Bags have the potential to leak.", "recall_initiation_date": "20221125", "center_classification_date": "20221205", "termination_date": "20240823", "report_date": "20221214", "code_info": "Lot: 0061832446 Exp. 31 Oct 2024"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0044-2023", "product_description": "PAPAVERINE / PHENTOLAMINE / PROSTAGLANDIN INJ 75MG/2.5MG/50MCG/ BOTTLE SOLUTION, 5 ML vial, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lot: 65425, BUD: 10/13/2022"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077794"], "brand_name": ["OXCARBAZEPINE"], "generic_name": ["OXCARBAZEPINE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["62756-183", "62756-184", "62756-185"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OXCARBAZEPINE"], "rxcui": ["312136", "312137", "312138"], "spl_id": ["56aeed00-02fa-483d-b4be-45362e10f5ff"], "spl_set_id": ["7ecd5eef-46f4-407f-9b63-ba65adb3eced"], "package_ndc": ["62756-183-83", "62756-183-88", "62756-183-08", "62756-183-13", "62756-183-18", "62756-184-83", "62756-184-88", "62756-184-08", "62756-184-13", "62756-184-18", "62756-185-83", "62756-185-88", "62756-185-08", "62756-185-13", "62756-185-18"], "is_original_packager": [true], "upc": ["0362756183834", "0362756185838", "0362756184831"], "nui": ["N0000175753", "N0000008486"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["VZI5B1W380"]}, "product_type": "Drugs", "event_id": "91311", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0085-2023", "product_description": "Oxcarbazepine Tablets 600mg, packaged in a) 100- count bottles (NDC 62756-185-88), b) 500-count bottles (NDC 62756-185-13), c)1000-count bottles (NDC 62756-185-18), Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited Halol-Baroda Highway, Halol-389 350, Gujarat, India.", "product_quantity": "Lot HAC1474A: 4296 Bottles, Lot HAC1474B: 145 Bottles, Lot HAC1503A: 2124 Bottles", "reason_for_recall": "Presence of foreign substance", "recall_initiation_date": "20221201", "center_classification_date": "20221219", "termination_date": "20230913", "report_date": "20221228", "code_info": "a) Lot HAC1474A, Expires 03/2023 b) Lot HAC1503A, Expires 03/2023 c) Lot HAC1474B, Expires 03/2023", "more_code_info": ""}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91132", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0064-2023", "product_description": "PF-Labetalol HCl Injection, USP 20 mg/4 mL (5 mg/mL) vial, Rx Only, Nephron 503B Outsourcing Facility 4500 12th Street Extension West Columbia, SC 29172, NDC 69374-946-34, UPC 3 69374 94634 6.", "product_quantity": "34,020 vials", "reason_for_recall": "CGMP Deviations: Potential for cross contamination due to product carry over.", "recall_initiation_date": "20221110", "center_classification_date": "20221117", "termination_date": "20240924", "report_date": "20221123", "code_info": "Lots: LB2001B Exp. 01/07/2023; LB2005B Exp. 03/02/2023"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0048-2023", "product_description": "PAPAVERINE/PHENTOLAMINE/PROSTAGLANDIN INJ 150/5/50MCG / VIAL SOLUTION, 10 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "5 vials", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lot: 65594, BUD: 10/16/2022"}, {"status": "Terminated", "city": "East Hanover", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA050715"], "brand_name": ["NEORAL"], "generic_name": ["CYCLOSPORINE"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "product_ndc": ["0078-0246", "0078-0248", "0078-0274"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CYCLOSPORINE"], "rxcui": ["241834", "835886", "835894", "835899", "835909", "835911"], "spl_id": ["617d71af-24cb-470f-927a-0f7f40fc344c"], "spl_set_id": ["94461af3-11f1-4670-95d4-2965b9538ae3"], "package_ndc": ["0078-0246-61", "0078-0246-15", "0078-0248-61", "0078-0248-15", "0078-0274-22"], "is_original_packager": [true], "nui": ["N0000175457", "N0000175458", "N0000182141", "N0000185503"], "pharm_class_epc": ["Calcineurin Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Calcineurin Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "unii": ["83HN0GTJ6D"]}, "product_type": "Drugs", "event_id": "90862", "recalling_firm": "Novartis Pharmaceuticals Corporation", "address_1": "1 Health Plz", "address_2": "N/A", "postal_code": "07936-1016", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1543-2022", "product_description": "Neoral soft gelatin capsules (cyclosporine capsules, USP) Modified, 25 mg, Rx Only, 30 Soft Gelatin Capsules per carton, Mfg by: Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, NDC # 0078-0246-15.", "product_quantity": "132,999 cartons", "reason_for_recall": "CGMP deviations: Out of specification results obtained during routine stability testing for ethanol content.", "recall_initiation_date": "20220916", "center_classification_date": "20220926", "termination_date": "20240311", "report_date": "20221005", "code_info": "Lot # APCD162, Exp. 01/2023"}, {"status": "Ongoing", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018090"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["ICU Medical Inc."], "product_ndc": ["0990-7730", "0990-7983", "0990-7984", "0990-7985"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807548", "1807549", "1807550", "1807551", "1807552", "1807627", "1807630", "1807631", "1807632", "1807633", "1807634", "1807639"], "spl_id": ["beda0179-f554-4c42-b60e-68615243d312"], "spl_set_id": ["5f372b75-d7a4-471e-8ac6-290040fc84b0"], "package_ndc": ["0990-7730-36", "0990-7730-37", "0990-7983-61", "0990-7983-02", "0990-7983-03", "0990-7983-09", "0990-7983-55", "0990-7983-53", "0990-7984-37", "0990-7984-20", "0990-7984-13", "0990-7984-23", "0990-7984-36", "0990-7985-02", "0990-7985-03", "0990-7985-09"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "91113", "recalling_firm": "ICU Medical Inc", "address_1": "600 N Field Dr", "address_2": "N/A", "postal_code": "60045-4835", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0062-2023", "product_description": "0.9% Sodium Chloride Injection, USP, 100 mL flexible container bag, Rx Only, ICU Medical, Inc., Lake Forest, Illinois, 60045, USA, NDC 0990-7984-37", "product_quantity": "137,120 bags", "reason_for_recall": "Lack of assurance of sterility: Bags have the potential to leak in the flexible containers which may compromise sterility.", "recall_initiation_date": "20221109", "center_classification_date": "20221116", "report_date": "20221123", "code_info": "Lot: 5829936, Exp. MAR 31 2024"}, {"status": "Ongoing", "city": "Dayton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202675"], "brand_name": ["GLYCOPYRROLATE"], "generic_name": ["GLYCOPYRROLATE"], "manufacturer_name": ["Aurolife Pharma LLC"], "product_ndc": ["13107-014", "13107-015"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GLYCOPYRROLATE"], "rxcui": ["197738", "197739"], "spl_id": ["cb079e3f-17d8-47ce-ae8d-41f6bd025630"], "spl_set_id": ["677f8495-a870-45b6-bb65-75b449f040ce"], "package_ndc": ["13107-014-01", "13107-015-01"], "is_original_packager": [true], "upc": ["0313107014017"], "unii": ["V92SO9WP2I"]}, "product_type": "Drugs", "event_id": "91319", "recalling_firm": "Aurolife Pharma, LLC", "address_1": "2400 US Highway 130", "address_2": "", "postal_code": "08810-1519", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide in the USA and Puerto Rico.", "recall_number": "D-0087-2023", "product_description": "Glycopyrrolate Tablets, USP, 1 mg, 100 tablets, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, NDC 13107-014-01", "product_quantity": "7344 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20221216", "center_classification_date": "20221222", "report_date": "20221228", "code_info": "Lots: 01422002A1, Expiry: 12/2023; 01421078A3, Expiry: 09/2023", "more_code_info": ""}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0057-2023", "product_description": "VORICONAZOLE OPTH SOLUTION 2% STERILE SOLN, 10 ML droptainer, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "1 droptainer", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lot: 66757, BUD: 10/14/2022"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201633"], "brand_name": ["BUPRENORPHINE AND NALOXONE"], "generic_name": ["BUPRENORPHINE AND NALOXONE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["62756-969", "62756-970"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBLINGUAL"], "substance_name": ["BUPRENORPHINE HYDROCHLORIDE", "NALOXONE HYDROCHLORIDE DIHYDRATE"], "rxcui": ["351266", "351267"], "spl_id": ["902e3bce-c45e-409e-876e-74b1ab2de4ef"], "spl_set_id": ["91b68606-05de-4586-ae31-07e8cc9160cf"], "package_ndc": ["62756-969-83", "62756-969-64", "62756-970-83", "62756-970-64"], "is_original_packager": [true], "upc": ["0362756969834"], "unii": ["56W8MW3EN1", "5Q187997EE"]}, "product_type": "Drugs", "event_id": "91033", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide with the United States", "recall_number": "D-0024-2023", "product_description": "Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, 30-count bottles, Rx only,  Distributed by:  Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India; NDC 62756-970-83", "product_quantity": "N/A", "reason_for_recall": "Presence of Foreign Substance", "recall_initiation_date": "20221018", "center_classification_date": "20221031", "termination_date": "20230907", "report_date": "20221109", "code_info": "Lot #: DNC1129A, Exp 06/2023 Lot #: DNC1740A, Exp 09/2023"}, {"status": "Terminated", "city": "Fairfield", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA211364"], "brand_name": ["CLOMIPRAMINE HYDROCHLORIDE"], "generic_name": ["CLOMIPRAMINE HYDROCHLORIDE"], "manufacturer_name": ["Leading Pharma, LLC"], "product_ndc": ["69315-165", "69315-167", "69315-166"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLOMIPRAMINE HYDROCHLORIDE"], "rxcui": ["857297", "857301", "857305"], "spl_id": ["2c3f1daf-c6c1-466a-af1c-4e0a71777828"], "spl_set_id": ["fa0d4de8-c96e-429d-a65c-928afbf46863"], "package_ndc": ["69315-167-03", "69315-167-01", "69315-167-09", "69315-166-03", "69315-166-01", "69315-166-09", "69315-165-03", "69315-165-01"], "is_original_packager": [true], "upc": ["0369315167014", "0369315167038", "0369315165034", "0369315167090"], "unii": ["2LXW0L6GWJ"]}, "product_type": "Drugs", "event_id": "90853", "recalling_firm": "Leading Pharma, LLC", "address_1": "3 Oak Rd", "address_2": "N/A", "postal_code": "07004-2903", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1546-2022", "product_description": "ClomiPRAMINE Hydrochloride Capsules, USP 25mg, 100-count bottles, Rx only, LEADING PHARMA, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-167-01", "product_quantity": "960 bottles (100 capsules)", "reason_for_recall": "Superpotent Drug: Assay value found to be 110.6% in Chlomipramine Hydrocholoride capsules", "recall_initiation_date": "20220823", "center_classification_date": "20220928", "termination_date": "20230928", "report_date": "20221005", "code_info": "Lot#: B14221, Exp. Date 02/2023"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077690"], "brand_name": ["QUINAPRIL"], "generic_name": ["QUINAPRIL"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-554", "68180-556", "68180-557", "68180-558", "68180-559"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["QUINAPRIL HYDROCHLORIDE"], "rxcui": ["312748", "312749", "312750", "314203"], "spl_id": ["a9598a21-6f99-4c86-ace6-b5638da2bec8"], "spl_set_id": ["8ded0773-3aec-4e89-9836-d22a5a84abf0"], "package_ndc": ["68180-556-09", "68180-557-09", "68180-557-03", "68180-558-09", "68180-558-03", "68180-554-09", "68180-554-03", "68180-559-03", "68180-559-09"], "is_original_packager": [true], "upc": ["0368180559092", "0368180556091"], "unii": ["33067B3N2M"]}, "product_type": "Drugs", "event_id": "91279", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed by major distribution chains nationwide.", "recall_number": "D-0088-2023", "product_description": "Quinapril Tablets USP, 40 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, by: Lupin Limited, Goa 403 722 India, NDC# 68180-554-09", "product_quantity": "30,612 bottles", "reason_for_recall": "CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.", "recall_initiation_date": "20221207", "center_classification_date": "20221223", "termination_date": "20240801", "report_date": "20221228", "code_info": "Lot #: G100533, G100534, Exp. 12/2022; G203071, Exp. 03/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Alpharetta", "state": "GA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA040573"], "brand_name": ["PHENYTOIN SODIUM"], "generic_name": ["PHENYTOIN SODIUM"], "manufacturer_name": ["Acella Pharmaceuticals, LLC"], "product_ndc": ["42192-614"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["PHENYTOIN SODIUM"], "rxcui": ["1670351", "1670353"], "spl_id": ["ae14cce7-f65a-45e0-8ff4-9388d0a806d2"], "spl_set_id": ["6922f32f-8bed-4c09-8103-27987bcbd104"], "package_ndc": ["42192-614-10", "42192-614-30", "42192-614-02"], "is_original_packager": [true], "unii": ["4182431BJH"]}, "product_type": "Drugs", "event_id": "91149", "recalling_firm": "Acella Pharmaceuticals, LLC", "address_1": "1880 Mcfarland Pkwy Ste 110", "address_2": "N/A", "postal_code": "30005-1795", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0069-2023", "product_description": "Phenytoin Sodium Injection, USP 100 mg/2 mL, NDC 42192-614-02, packaged in 10 x 2 mL vials per carton, NDC 42192-614-10, Rx only, Manufactured for: Acella Pharmaceuticals, LLC Alpharetta, GA 30005", "product_quantity": "574 cartons", "reason_for_recall": "Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.", "recall_initiation_date": "20221114", "center_classification_date": "20221123", "termination_date": "20240821", "report_date": "20221130", "code_info": "Lot: E025A001 Exp. 07/2023"}, {"status": "Ongoing", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "91161", "recalling_firm": "Noven Pharmaceuticals Inc", "address_1": "11960 Sw 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0071-2023", "product_description": "Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours, (1.6 mg/hr), 30 patches per box, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC 68968-5553-3.", "product_quantity": "3977 boxes", "reason_for_recall": "Defective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal patches.", "recall_initiation_date": "20221116", "center_classification_date": "20221128", "report_date": "20221207", "code_info": "Lot: 91316 Exp. 02/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M012"], "brand_name": ["SINUS PRESSURE, PAIN AND COUGH"], "generic_name": ["ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL"], "manufacturer_name": ["Walgreen Company"], "product_ndc": ["0363-6171"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN", "DEXTROMETHORPHAN HYDROBROMIDE", "GUAIFENESIN", "PHENYLEPHRINE HYDROCHLORIDE"], "rxcui": ["1110988"], "spl_id": ["f2cc7da1-4d7a-4ecf-ab64-fe8889ae9630"], "spl_set_id": ["97554f40-f9aa-4dbf-a6f2-de6197236ab4"], "package_ndc": ["0363-6171-09"], "is_original_packager": [true], "upc": ["0311917009476"], "nui": ["N0000193956", "N0000008867", "N0000009560"], "pharm_class_epc": ["Expectorant [EPC]"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "unii": ["362O9ITL9D", "9D2RTI9KYH", "495W7451VQ", "04JA59TNSJ"]}, "product_type": "Drugs", "event_id": "90983", "recalling_firm": "LNK International, Inc.", "address_1": "55 Arkay Dr", "address_2": "N/A", "postal_code": "11788-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0014-2023", "product_description": "NDC 0363-6171-09 Walgreens Sinus Pressure, Pain & Cough  ACETAMINOPHEN/ PAIN RELIEVER DEXTROMETHORPHAN HBr/ COUGH SUPPRESSANT GUAIFENESIN/ EXPECTORANT PHENYLEPHRINE HCl/ NASAL DECONGESTANT Maximum Strength    Decongestant Free DISTRIBUTED BY: WALGREENS CO. 200 WILMOT RD., DEERFIELD, IL 60015 walgreens.com", "product_quantity": "66,384 boxes of twenty tablets each", "reason_for_recall": "Boxes mislabeled to read \"Decongestant Free\", but the product contains Phenylephrine HCI 5mg", "recall_initiation_date": "20221011", "center_classification_date": "20221018", "termination_date": "20230725", "report_date": "20221026", "code_info": "P129910   P129911   P130240", "more_code_info": ""}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90992", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "N/A", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-0012-2023", "product_description": "Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Manufactured by Patheon Pharmaceuticals Inc., OH, Packaged by GSMS, Incorporated, CA, NDC 51407-322-30", "product_quantity": "N/A", "reason_for_recall": "Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).", "recall_initiation_date": "20221006", "center_classification_date": "20221017", "termination_date": "20250319", "report_date": "20221026", "code_info": "Lot #: GS036715, GS037569, GS038132, GS038665, GS038750, GS039565, GS039997, GS040673, Exp 10/31/2022; GS040674, GS041237, GS041652, GS042152, GS043365, Exp 3/31/2023; GS045441, GS045677, GS046111, Exp 2/29/2024.", "more_code_info": ""}, {"status": "Completed", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA207719"], "brand_name": ["PHYTONADIONE"], "generic_name": ["PHYTONADIONE"], "manufacturer_name": ["Dr.Reddy's Laboratories Inc"], "product_ndc": ["43598-405"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["PHYTONADIONE"], "rxcui": ["1670192"], "spl_id": ["c4a2bf44-0ad2-c0d2-164f-562ba6df930c"], "spl_set_id": ["02445c07-7b4b-cd70-54e8-ebefc814f547"], "package_ndc": ["43598-405-11", "43598-405-16"], "is_original_packager": [true], "nui": ["N0000175965", "N0000175982", "M0022806", "N0000180191", "N0000175966"], "pharm_class_pe": ["Increased Prothrombin Activity [PE]", "Reversed Anticoagulation Activity [PE]"], "pharm_class_cs": ["Vitamin K [CS]"], "pharm_class_epc": ["Vitamin K [EPC]", "Warfarin Reversal Agent [EPC]"], "unii": ["A034SE7857"]}, "product_type": "Drugs", "event_id": "90868", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-0007-2023", "product_description": "Phytonadione Injectable Emulsion USP, 10 mg/mL, 25x 1 mL single dose ampules per carton, Rx only, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, NDC 43598-405-16", "product_quantity": "2,838 ampules", "reason_for_recall": "Failed Stability Specifications: Out of specification results reported at 12-month stability testing for aluminum content.", "recall_initiation_date": "20220914", "center_classification_date": "20221006", "report_date": "20221012", "code_info": "Lot # ACB101, Exp 03/2023"}, {"status": "Terminated", "city": "Lenoir", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA211091"], "brand_name": ["SODIUM BICARBONATE"], "generic_name": ["SODIUM BICARBONATE"], "manufacturer_name": ["Exela Pharma Sciences, LLC"], "product_ndc": ["51754-5001", "51754-5011", "51754-5002", "51754-5012"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM BICARBONATE"], "rxcui": ["807284", "1868486", "1923484", "2198792"], "spl_id": ["4da0ba66-756d-4b4d-8018-81ca16578ef1"], "spl_set_id": ["e9698a4f-1a95-4f28-a945-e8009d1d6dd4"], "package_ndc": ["51754-5001-5", "51754-5001-4", "51754-5011-4", "51754-5002-5", "51754-5012-4", "51754-5001-1"], "is_original_packager": [true], "unii": ["8MDF5V39QO"]}, "product_type": "Drugs", "event_id": "90956", "recalling_firm": "Exela Pharma Sciences LLC", "address_1": "1245 Blowing Rock Blvd", "address_2": "N/A", "postal_code": "28645-3618", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0022-2023", "product_description": "8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx only, Manufactured and Distributed by: Exela Pharma Sciences, LLC Lenoir, NC 28645. Carton NDC 51754-5001-5, vial NDC 51754-5001-1", "product_quantity": "2,123,040 vials", "reason_for_recall": "Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration", "recall_initiation_date": "20221004", "center_classification_date": "20221027", "termination_date": "20251010", "report_date": "20221102", "code_info": "Lot # : P0001370, P0001371, P0001372, Exp. 10/2023; P0001433, P0001434 Exp. 11/2023; P0001443, P0001468, P0001469, P0001470, P0001495, P0001505, P0001506, P0001509, P0001510, P0001511, P0001512 Exp. 12/2023; P0001560, P0001561, P0001562, P0001564, P0001566, P0001567, P0001568 Exp. 01/2024; P0001571, P0001572, P0001573, P0001574, P0001578, P0001579, P0001580, P0001583, P0001586, P0001587, P0001588, P0001593, P0001594, P0001610, P0001618, P0001619, P0001654 Exp. 02/2024; P0001644, P0001645, P0001646, P0001662, P0001664 Exp. 03/2024; P0001730 Exp. 05/2024.", "more_code_info": ""}, {"status": "Terminated", "city": "Westborough", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91243", "recalling_firm": "Atlantic Management Resources Ltd.", "address_1": "39 Harvey Ln", "address_2": "N/A", "postal_code": "01581-3013", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide and Australia", "recall_number": "D-0081-2023", "product_description": "Neuroquell Plus, Advanced Formula, A Homeopathic Drug, Calendula Oil packaged in 0.22 Fl. oz. (6.6 mL) bottles, Mfg. for/Dist. By Claire Ellen Topicals, P.O. Box 901 Westborough, MA 01581, USA, NDC# 66233712-01.", "product_quantity": "461 bottles", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20221212", "center_classification_date": "20221213", "termination_date": "20230920", "report_date": "20221221", "code_info": "Lot Code B-02"}, {"status": "Terminated", "city": "Lenoir", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA211091"], "brand_name": ["SODIUM BICARBONATE"], "generic_name": ["SODIUM BICARBONATE"], "manufacturer_name": ["Exela Pharma Sciences, LLC"], "product_ndc": ["51754-5001", "51754-5011", "51754-5002", "51754-5012"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM BICARBONATE"], "rxcui": ["807284", "1868486", "1923484", "2198792"], "spl_id": ["4da0ba66-756d-4b4d-8018-81ca16578ef1"], "spl_set_id": ["e9698a4f-1a95-4f28-a945-e8009d1d6dd4"], "package_ndc": ["51754-5001-5", "51754-5001-4", "51754-5011-4", "51754-5002-5", "51754-5012-4", "51754-5001-1"], "is_original_packager": [true], "unii": ["8MDF5V39QO"]}, "product_type": "Drugs", "event_id": "91197", "recalling_firm": "Exela Pharma Sciences LLC", "address_1": "1245 Blowing Rock Blvd", "address_2": "N/A", "postal_code": "28645-3618", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0079-2023", "product_description": "8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx only, Manufactured and Distributed by: Exela Pharma Sciences, LLC Lenoir, NC 28645. Carton NDC 51754-5001-5, vial NDC 51754-5001-1.", "product_quantity": "489,600 vials", "reason_for_recall": "Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.", "recall_initiation_date": "20221128", "center_classification_date": "20221213", "termination_date": "20251010", "report_date": "20221221", "code_info": "Lots: P0001178 Exp. 05/2023; P0001298, P0001301, P0001313, P0001314, P0001317 Exp. 08/2023; P0001330, P0001464  Exp. 09/2023; P0001442 Exp. 11/2023;  P0001467, P0001472, P0001486, P0001532 Exp. 12/2023."}, {"status": "Terminated", "city": "Lenoir", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA211091"], "brand_name": ["SODIUM BICARBONATE"], "generic_name": ["SODIUM BICARBONATE"], "manufacturer_name": ["Civica"], "product_ndc": ["72572-740"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM BICARBONATE"], "rxcui": ["1868486"], "spl_id": ["98efb401-5361-41ff-979a-6857768a144c"], "spl_set_id": ["a10fdfbc-94a0-49ab-b26c-de1df042bc89"], "package_ndc": ["72572-740-20", "72572-740-25"], "is_original_packager": [true], "upc": ["0372572740258"], "unii": ["8MDF5V39QO"]}, "product_type": "Drugs", "event_id": "90956", "recalling_firm": "Exela Pharma Sciences LLC", "address_1": "1245 Blowing Rock Blvd", "address_2": "N/A", "postal_code": "28645-3618", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0023-2023", "product_description": "8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx Only, Mfd for: Civica, Inc. Lehi, Utah 84043, Mfd by: Exela Pharma Sciences, LLC, Lenoir, NC 28645, Carton NDC 72572-740-20, vial NDC 72572-740-1.", "product_quantity": "148,920", "reason_for_recall": "Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration", "recall_initiation_date": "20221004", "center_classification_date": "20221027", "termination_date": "20251010", "report_date": "20221102", "code_info": "Lot #: P0001497 Exp. 12/2023; P0001600 Exp. 02/2024; P0001663 Exp. 03/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0041-2023", "product_description": "PAP/PHEN/PROSTAG/ATROPINE INJ 150MG/7.5MG/75MCG/1MG bottle solution, 5 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "2 vials", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lots: 66369, BUD: 11/06/2022; 66540, BUD: 11/09/2022"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0053-2023", "product_description": "SEMAGLUTIDE INJECTION 5MG/ML (0.25MG/0.05ML) SOLN, various amounts in unit dose vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "800.5 mL in unit dose vials", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lots: 65680, BUD: 10/11/2022; 66043, BUD: 10/15/2022; 66372, BUD: 10/23/2022; 66597, BUD: 10/29/2022"}, {"status": "Ongoing", "city": "Thornton", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91084", "recalling_firm": "Adam's Polishes LLC", "address_1": "8225 N Valley Hwy", "address_2": "N/A", "postal_code": "80221-4810", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0067-2023", "product_description": "Adam's Polishes ALCOHOL BASED HAND SANITIZER, isopropyl alcohol 75% v/v, packaged in a) 4 fl. oz (118) spray bottle, NDC 74943-125-04; b) 8 fl. oz (237 mL) spray bottle, NDC 74943-125-08; c) 1 PINT / 16 fl. oz (475 ml.) spray bottle, NDC 74943-125-16; and d) 1 GALLON / 128 fl. oz. (3,785 ml.) jug, NDC 74943-125-28, Manufactured by B&B Blending, LLC, Northglenn, CO.", "product_quantity": "3,441 gallons total", "reason_for_recall": "CGMP Deviations: Other lots of hand sanitizer are being recalled because they were manufactured under the same conditions as the product lot found to contain methanol.", "recall_initiation_date": "20221105", "center_classification_date": "20221122", "report_date": "20221123", "code_info": "Lots: 133470, 133471, 133472, 133473, 133474, 133476, 133477, 133478, 133479, 133480, 133481, 133482, 133483, 137731, 137732, 137733, 137734, 139322, 143327"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0030-2023", "product_description": "CEFTAZIDIME INTRAVITREAL 2.25MG/0.1ML Solution, 0.5 mL syringe, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "12 syringes", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lots: 65434, BUD: 10/13/2022; 66349, BUD: 11/05/2022; 66868, BUD: 11/18/2022"}, {"status": "Terminated", "city": "Westborough", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91243", "recalling_firm": "Atlantic Management Resources Ltd.", "address_1": "39 Harvey Ln", "address_2": "N/A", "postal_code": "01581-3013", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide and Australia", "recall_number": "D-0084-2023", "product_description": "Menastil, A Homeopathic Formula, Calendula Oil packaged in 1/8 Fl. oz. (3.5 g) bottles, Mfg. for/Dist. By Claire Ellen Topicals, P.O. Box 901 Westborough, MA 01581, USA, NDC# 66233-711-01.", "product_quantity": "26 bottles", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20221212", "center_classification_date": "20221213", "termination_date": "20230920", "report_date": "20221221", "code_info": "Lot Code A-01"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0029-2023", "product_description": "BRILLIANT BLUE G, 0.04% Solution, 2 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "86 vials", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lot: 60448 BUD: 10/31/2022"}, {"status": "Ongoing", "city": "Thornton", "state": "CO", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "91084", "recalling_firm": "Adam's Polishes LLC", "address_1": "8225 N Valley Hwy", "address_2": "N/A", "postal_code": "80221-4810", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0066-2023", "product_description": "Adam's Polishes ALCOHOL BASED HAND SANITIZER, isopropyl alcohol 75% v/v, packaged in a) 4 fl. oz (118) spray bottle, NDC 74943-125-04; b) 8 fl. oz (237 mL) spray bottle, NDC 74943-125-08; c) 1 PINT / 16 fl. oz (475 ml.) spray bottle, NDC 74943-125-16; and d) 1 GALLON / 128 fl. oz. (3,785 ml.) jug, NDC 74943-125-28, Manufactured by B&B Blending, LLC, Northglenn, CO.", "product_quantity": "3,441 gallons total", "reason_for_recall": "Chemical Contamination: FDA analysis found 1 lot of Adam's Polishes ALCOHOL BASED HAND SANITIZER isopropyl alcohol 75% v/v to contain methanol.", "recall_initiation_date": "20221105", "center_classification_date": "20221122", "report_date": "20221123", "code_info": "Lot: 133475"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0027-2023", "product_description": "ACETYLCYSTEINE OPTH 5% Solution, 15 mL droptainers, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "2 droptainers", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lots: 66017, BUD: 10/13/2022; 66177, BUD: 10/19/2022"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0056-2023", "product_description": "VANCOMYCIN INTRAVITREAL 1MG/0.1ML SOLUTION, 0.5 mL syringes, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "12 syringes", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lots: 65432, BUD: 10/13/2022; 66347, BUD: 11/05/2022; 66864, BUD: 11/18/2022"}, {"status": "Terminated", "city": "Medina", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["505G(a)(3)"], "brand_name": ["FOAMFRESH DYE FREE ANTIBACTERIAL HAND WASH"], "generic_name": ["CHLOROXYLENOL"], "manufacturer_name": ["Woodbine Products Company"], "product_ndc": ["11429-1010"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLOROXYLENOL"], "rxcui": ["1435989"], "spl_id": ["27c46f23-b193-f4ff-e063-6394a90a4038"], "spl_set_id": ["ba205f78-6e3f-483e-a37a-537f6917b00c"], "package_ndc": ["11429-1010-1", "11429-1010-7", "11429-1010-3", "11429-1010-8"], "is_original_packager": [true], "unii": ["0F32U78V2Q"]}, "product_type": "Drugs", "event_id": "90846", "recalling_firm": "Woodbine Products Co Inc", "address_1": "915 W Smith Rd", "address_2": "N/A", "postal_code": "44256-2446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "NC", "recall_number": "D-0006-2023", "product_description": "Antibacterial Foaming Wash with Hydria Moisturizing Formula, Cucumber-Melon Scent, 1250 mL (42 fl oz.), Manufactured for: Triple S, 800-323-2251, Made in USA, NDC 11429-1010-8", "product_quantity": "595 cases (4 bottles per case)", "reason_for_recall": "Labeling: Not Elsewhere Classified - Incorrect label-incorrect scent listed on label.", "recall_initiation_date": "20220830", "center_classification_date": "20221006", "termination_date": "20230928", "report_date": "20221012", "code_info": "Lot #: VDAF017, Exp 4/24; VDAF018, Exp 5/24"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0042-2023", "product_description": "PAPAVERINE / PHENTOLAMINE / PROSTAGLANDIN 150MG / 2.5MG / 50MCG SOLUTION, 5 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "56 vials", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lots: 64409, BUD: 04/08/2023; 60849, BUD: 05/23/2023"}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207802"], "brand_name": ["FLUNISOLIDE"], "generic_name": ["FLUNISOLIDE"], "manufacturer_name": ["Ingenus Pharmaceuticals, LLC"], "product_ndc": ["50742-317"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["NASAL"], "substance_name": ["FLUNISOLIDE"], "rxcui": ["1797863"], "spl_id": ["139fb92c-bb10-4ee9-8572-679ac540aa27"], "spl_set_id": ["f39cae46-c68f-47ef-82f3-4fd3dd46c74c"], "package_ndc": ["50742-317-25"], "is_original_packager": [true], "unii": ["QK4DYS664X"], "upc": ["350742317257"]}, "product_type": "Drugs", "event_id": "90934", "recalling_firm": "Ingenus Pharmaceuticals Llc", "address_1": "4190 Millenia Blvd", "address_2": "N/A", "postal_code": "32839-6408", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0010-2023", "product_description": "Flunisolide Nasal Solution, USP 0.025%, 25 mL bottles, Rx only, Manufactured for: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408;  NDC 50742-317-25 UPC 3 50742 31725 7", "product_quantity": "6176 bottles", "reason_for_recall": "Out of specification for related substances (impurities).", "recall_initiation_date": "20220930", "center_classification_date": "20221017", "report_date": "20221026", "code_info": "Lot #: 22E040 Exp. 07/2023; 22F038 Exp. 08/2023", "more_code_info": ""}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0036-2023", "product_description": "LIDOCAINE EPINEPHRINE BUFFERED 2%/1:1000 Solution, 10 mL syringe, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "7 syringes", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lot: 66591, BUD: 11/12/2022"}, {"status": "Completed", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203701"], "brand_name": ["ACYCLOVIR SODIUM"], "generic_name": ["ACYCLOVIR SODIUM"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-154", "55150-155"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ACYCLOVIR SODIUM"], "rxcui": ["1734932", "1734934"], "spl_id": ["410e306b-e8b9-4ff5-b703-a3005eec272f"], "spl_set_id": ["ae921e4e-b8ae-4a45-acc1-32e5e719812b"], "package_ndc": ["55150-154-10", "55150-155-20"], "is_original_packager": [true], "upc": ["0355150155200", "0355150154104"], "unii": ["927L42J563"]}, "product_type": "Drugs", "event_id": "90896", "recalling_firm": "AuroMedics Pharma LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0013-2023", "product_description": "Acyclovir Sodium Injection, 500mg/10mL (50mg/mL), 10 mL Single Dose Vial, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ  08520; Made in India, NDC 55150-154-10.", "product_quantity": "89400 vials", "reason_for_recall": "Presence of Particulate Matter: Customer complaint for a dark red, brown and black particulate floating inside vial.", "recall_initiation_date": "20220926", "center_classification_date": "20221018", "report_date": "20221026", "code_info": "Lot: AC22006, Exp 08/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Temple Terrace", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "91283", "recalling_firm": "BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy", "address_1": "7802 E Telecom Pkwy", "address_2": "N/A", "postal_code": "33637-0928", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "BayCare Health System hospitals in FL", "recall_number": "D-0086-2023", "product_description": "Iohexol (300 mg Iodine/mL), 2.4 g Iodine/8 ml, Total Volume 8 ml in 10 ml syringe, 5-count syringes packaged in a bag labeled as Omnipaque (iohexol) 300 mg I/mL, 2.4g Iodine/8 mL in a 10 mL syringe, Compounded with GE Healthcare product, Each mL contains (647 mg) of iohexol as 300 mg of organically bound iodine, 1.21 mg tromethamine, and 0.1 mg edetate calcium disodium, For Injection or oral use; Rx Only, BayCare Central Pharmacy, 7802 Telecom Parkway, Temple Terrace, FL 33637.", "product_quantity": "250 syringes", "reason_for_recall": "Labeling: Label Error on Declared Strength: syringes mislabeled as 300 mg iodine/mL contained product 350 mg iodine/mL", "recall_initiation_date": "20221201", "center_classification_date": "20221222", "termination_date": "20240315", "report_date": "20221221", "code_info": "Lot: IOHE2.420221128, Exp. 12/7/2022"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0028-2023", "product_description": "AUTOLOGUS TEARS SERUM SOLN FULL STRENGTH, 3 mL droptainers, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "168 droptainers", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lots: 65521, BUD: 10/15/2022; 65545, BUD: 10/15/2022; 65605, BUD: 10/16/2022; 65658, BUD: 10/17/2022; 65733, BUD: 10/21/2022; 65894, BUD: 10/24/2022; 66019, BUD: 10/28/2022; 66120, BUD: 10/30/2022; 66388, BUD: 11/6/2022; 66755, BUD: 11/14/2022; 66870, UD: 11/18/2022; 66928, BUD: 11/19/2022"}, {"status": "Terminated", "city": "Arlington", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90828", "recalling_firm": "Justified Laboratories", "address_1": "2131 N Collins St", "address_2": "Ste 433-732", "postal_code": "76011-2849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0009-2023", "product_description": "Skincell Mole & Skin Corrector Serum, 1 fl. oz./30 mL jars,  Distributed By: Justified Laboratoires, Arlington, TX 76011 USA UPC 8 10077 53221 8", "product_quantity": "Unknown", "reason_for_recall": "Marketed Without An Approved NDA/ANDA; Unapproved new drug", "recall_initiation_date": "20220909", "center_classification_date": "20221007", "termination_date": "20230810", "report_date": "20221019", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205710"], "brand_name": ["BUDESONIDE"], "generic_name": ["BUDESONIDE"], "manufacturer_name": ["Cipla USA Inc."], "product_ndc": ["69097-318", "69097-319", "69097-321"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUDESONIDE"], "rxcui": ["252559", "349094", "351109"], "spl_id": ["664e2f07-caa9-41d7-9aa9-0b744c858de8"], "spl_set_id": ["c52c5382-1400-44b9-95be-a30e1cf706da"], "package_ndc": ["69097-318-86", "69097-318-87", "69097-318-32", "69097-318-53", "69097-319-86", "69097-319-87", "69097-319-32", "69097-319-53", "69097-321-86", "69097-321-87", "69097-321-32", "69097-321-53"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["Q3OKS62Q6X"]}, "product_type": "Drugs", "event_id": "90864", "recalling_firm": "CIPLA", "address_1": "10 Independence Blvd", "address_2": "N/A", "postal_code": "07059-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-1545-2022", "product_description": "Budesonide Inhalation Suspension 0.25mg/2mL, For Inhalation Only, Rx Only, 1 envelope x five 2 mL Single Dose Ampules per pouch, Sterile Suspension, Manufactured by: Cipla Ltd., India, Manufactured for Cipla USA Inc., Warren NJ, NDC# 69097-318-86.", "product_quantity": "641,160 ampules", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220915", "center_classification_date": "20220927", "termination_date": "20240110", "report_date": "20221005", "code_info": "Lot #s: GA20080, GA20081, GA20094, Exp. 01/2024"}, {"status": "Terminated", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91038", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "N/A", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0063-2023", "product_description": "Carvedilol Tablets, USP, 25 mg, 500-count bottles, Rx Only, Mfg: Mylan Pharmaceuticals Inc. Morgantown, WV 36505, Made in India, NDC 0378-3634-05", "product_quantity": "2,794 bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Tablets exceeds specification for weight and thickness.", "recall_initiation_date": "20221021", "center_classification_date": "20221116", "termination_date": "20230713", "report_date": "20221123", "code_info": "Lot #: 3150116, Exp 2/2025"}, {"status": "Completed", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078450"], "brand_name": ["QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE"], "generic_name": ["QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["65862-161", "65862-162", "65862-163"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "QUINAPRIL HYDROCHLORIDE"], "rxcui": ["310796", "310797", "310809"], "spl_id": ["5842ecc2-874a-481b-8997-afa9d862dc5d"], "spl_set_id": ["50a58159-9572-4445-9859-b392632597da"], "package_ndc": ["65862-161-90", "65862-162-30", "65862-162-90", "65862-163-90"], "is_original_packager": [true], "upc": ["0365862161901"], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["0J48LPH2TH", "33067B3N2M"]}, "product_type": "Drugs", "event_id": "90949", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0021-2023", "product_description": "Quinapril and Hydrochlorothiazide Tablets, USP 20mg/12.5mg, 90 Tablets bottles Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road  East Windsor, NJ 08520, Made in India, NDC 65862-162-90", "product_quantity": "9504 bottles", "reason_for_recall": "CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.", "recall_initiation_date": "20221005", "center_classification_date": "20221026", "report_date": "20221102", "code_info": "Lots QE2021005-A and QE2021010-A, exp 01/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Ontario", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90973", "recalling_firm": "Ultra Chem Labs Corp", "address_1": "4581 Brickell Privado St", "address_2": "N/A", "postal_code": "91761-7828", "voluntary_mandated": "N/A", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0016-2023", "product_description": "Proton Armor, Anti-Microbial Alcohol-Free Foaming Hand Sanitizer, kills 99.99% of germs, Odor Free, Family Safe, No Gels, Water Based, 24 Hour Germ Protection with Moisturizers for Sensitive Skin, a) 8 oz bottle, b) 32 oz bottle and c) 1.7 fl oz or 50 mL bottle, Supplier details: Ultra Chem Labs, Ontario, CA, Active Ingredients - Benzalkonium Chloride 0.13% (antimicrobial), ULS 8357 0.33% (antimicrobial shield), NDC 79208-001-50.", "product_quantity": "5-10 gallons", "reason_for_recall": "Chemical Contamination and CGMP Deviations: trace amounts of methanol found in one of the components during the manufacturing process.", "recall_initiation_date": "20220815", "center_classification_date": "20221021", "termination_date": "20240813", "report_date": "20221102", "code_info": "Batch: 20087131. No Expiration dates Product Code: a) 3020-8 (8 oz) b) 3020-3 (32 oz) c) 3020-5 (1.7 fl oz./50 mL)", "more_code_info": ""}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91263", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "N/A", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two different customers in MI.", "recall_number": "D-0077-2023", "product_description": "Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC: 23155-0490-01; MFG: Avet Pharmaceuticals Inc., East Brunswick, NJ  08816; Repackaged by: RemedyRepack Inc., Indiana, PA  15701, NDC #: 70518-3493-00.", "product_quantity": "9 boxes", "reason_for_recall": "Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.", "recall_initiation_date": "20221205", "center_classification_date": "20221207", "termination_date": "20230203", "report_date": "20221214", "code_info": "Lot # B1817019-082222, Exp. 02/24/2023; B1819127-082322, Exp. 02/26/2023"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0045-2023", "product_description": "PAPAVERINE / PHENTOLAMINE / PROSTAGLANDIN INJ 90MG/3MG/29.4MCG/ BOTTLE SOLUTION, 5 ML vial, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "2 vials", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lots: 66450, BUD: 11/07/2022; 66527, BUD: 11/09/2022"}, {"status": "Ongoing", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078177"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Fresenius Medical Care North America"], "product_ndc": ["49230-300"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807639"], "spl_id": ["26587576-d68d-4c98-e063-6394a90ac53d"], "spl_set_id": ["af5cdf1a-19f4-11e2-892e-0800200c9a66"], "package_ndc": ["49230-300-10"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "90997", "recalling_firm": "Fresenius Medical Care Holdings, Inc.", "address_1": "920 Winter St Bld 950", "address_2": "N/A", "postal_code": "02451-1521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0015-2023", "product_description": "0.9% Sodium Chloride Injection, USP, Each 100 mL contains: SODIUM CHLORIDE, USP - 900 mg, WATER FOR INJECTION, USP - qs, 1000mL Bag, 12 PK, Rx Only, Fresenius Medical Care North America, Waltham, MA 02451, NDC 49230-300-10", "product_quantity": "16,006 cases of twelve bags each", "reason_for_recall": "Lack of Assurance of Sterility: Leakage of 0.9% Sodium Chloride for Injection, 1L, 12pk Saline Solution.", "recall_initiation_date": "20221011", "center_classification_date": "20221020", "report_date": "20221026", "code_info": "Lot # 22EU05043, EXP 5/21/2023; 22HU05018, EXP 6/9/2023; 22HU05019, EXP 6/10/2023; 22HU05025, 22HU05026, EXP 6/12/2023; 22HU05049, EXP 6/22/2023; 22HU05053, EXP 6/24/2023; 22HU05054, 22HU05055, EXP 6/25/2023; 22HU06027, EXP 6/11/2023; 22HU06049, EXP 6/23/2023; 22HU06055, EXP 6/24/2023; 22HU06056, EXP 6/25/2023; 22JU05008, EXP 7/4/2023; 22KU06036, EXP 8/19/2023; 22JU06023, EXP 7/8/2023", "more_code_info": ""}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0052-2023", "product_description": "PROSTAGLANDIN E1 INJECTION SOLUTION 500MCG/ML SOLUTION, 1 ML vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "50 vials", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lots: 59993 BUD: 10/18/2022; 60932 BUD: 11/09/2022"}, {"status": "Terminated", "city": "Westborough", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91243", "recalling_firm": "Atlantic Management Resources Ltd.", "address_1": "39 Harvey Ln", "address_2": "N/A", "postal_code": "01581-3013", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide and Australia", "recall_number": "D-0082-2023", "product_description": "Neuroquell, A Homeopathic Drug, Calendula Oil, packaged in1/8 Fl. oz. (3.5 g) bottles, Mfg. for/Dist. By Claire Ellen Topicals, P.O. Box 901 Westborough, MA 01581, USA, NDC# 66233712-01.", "product_quantity": "51 bottles", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20221212", "center_classification_date": "20221213", "termination_date": "20230920", "report_date": "20221221", "code_info": "Lot Code B-02"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213725"], "brand_name": ["PANTOPRAZOLE SODIUM"], "generic_name": ["PANTOPRAZOLE SODIUM"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["62756-071"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PANTOPRAZOLE SODIUM"], "rxcui": ["763306"], "spl_id": ["d19d65d9-7bab-4a6f-9a79-ed3d32bd83d9"], "spl_set_id": ["38353b9e-63bd-47e8-b7cb-b198d1e901f9"], "package_ndc": ["62756-071-60", "62756-071-64"], "is_original_packager": [true], "upc": ["0362756071643"], "unii": ["6871619Q5X"]}, "product_type": "Drugs", "event_id": "91146", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0068-2023", "product_description": "Pantoprazole Sodium for Delayed-Release Oral Suspension*40 mg* suspension in apple juice or applesauce only Each packet contains 40 mg pantoprazole equivalent to 45.1 mg of pantoprazole sodium USP (sesquihydrate), Rx Only, distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, manufactured by: Sun Pharmaceutical Industries Limited Mohali, INDIA, NDC 62756-071-60", "product_quantity": "14, 064 (30 sachets in a carton)", "reason_for_recall": "Discoloration", "recall_initiation_date": "20220725", "center_classification_date": "20221122", "termination_date": "20230913", "report_date": "20221130", "code_info": "Lot #: MHC1317A, Exp 07/2023"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90880", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide and Puerto Rico", "recall_number": "D-1548-2022", "product_description": "Rifampin Capsules, USP, 300 mg, a) 30-count bottle (NDC 61748-018-30), b) 60-count bottle (NDC 61748-018-60), c) 100-count bottle (NDC 61748-018-01), Rx only, Distributed by: Akorn Operating Company, LLC, Gurnee, IL 60031.", "product_quantity": "177,439 bottles", "reason_for_recall": "Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).", "recall_initiation_date": "20220921", "center_classification_date": "20220928", "report_date": "20221005", "code_info": "Lot#: a) 3192827, Exp 10/31/2022; 3196136, Exp 12/31/2022; 3202198, Exp 07/31/2023; 3203658, Exp 07/31/2023; 3209114, Exp 11/30/2023; 3203851, Exp 02/29/2024; b) 3191254, Exp 09/30/2022;  3192820, Exp 09/30/2022; 3192822, Exp 10/31/2022; 3192824, Exp 10/31/2022; 3192825, Exp 10/31/2022; 3196141, Exp 01/31/2023; 3196143, Exp 02/28/2023; 3203870, Exp 11/30/2023; 3203871, Exp 02/29/2024; c) 3190636, Exp 09/30/2022; 3192813, Exp 09/30/2022; 3196132, Exp 12/31/2022; 3196133, Exp 12/31/2022; 3196138, Exp 01/31/2023; 3199702, Exp 03/31/2023; 3199703, Exp 03/31/2023"}, {"status": "Terminated", "city": "Malvern", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "90877", "recalling_firm": "ALMIRALL, LLC", "address_1": "101 Lindenwood Dr Ste 400", "address_2": "N/A", "postal_code": "19355-1769", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1549-2022", "product_description": "Xolegel (ketoconazole) gel 2%, 45 gram tubes, Rx only, Manufactured by: DPT Laboratories, San Antonio, TX 78215, NDC 16110-080-45", "product_quantity": "5,315 tubes", "reason_for_recall": "Failed Viscosity specification: Slightly higher OOS results obtained for viscosity", "recall_initiation_date": "20220916", "center_classification_date": "20220929", "termination_date": "20230713", "report_date": "20221005", "code_info": "Lot #: RGAF, Exp. Date 12/2022"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0032-2023", "product_description": "CYCLOSPORIN 0.07% OPTH 0.07% Solution in 10 mL bottles, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "67 bottles", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lots: 59638, BUD: 11/25/2022; 64261, BUD: 04/30/2023"}, {"status": "Terminated", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA079198"], "brand_name": ["OCTREOTIDE ACETATE"], "generic_name": ["OCTREOTIDE ACETATE"], "manufacturer_name": ["Mylan Institutional LLC"], "product_ndc": ["67457-239", "67457-245", "67457-246"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["OCTREOTIDE ACETATE"], "rxcui": ["1090558", "1090559", "1090560"], "spl_id": ["1bb19829-029a-4baf-a12c-ec04102dd79e"], "spl_set_id": ["2d78d5d1-77b2-4da1-98d4-d9c36e743ce2"], "package_ndc": ["67457-239-00", "67457-239-01", "67457-245-00", "67457-245-01", "67457-246-00", "67457-246-01"], "is_original_packager": [true], "unii": ["75R0U2568I"]}, "product_type": "Drugs", "event_id": "90974", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "N/A", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0058-2023", "product_description": "Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneous or Intravenous Use, Rx Only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., Made in Italy, NDC: 67457-246-00 (syringe), 67457-246-01 (carton).", "product_quantity": "22400 syringes", "reason_for_recall": "Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe.", "recall_initiation_date": "20221007", "center_classification_date": "20221108", "termination_date": "20240112", "report_date": "20221116", "code_info": "Lot #: AJ21002, Exp. 03/2024"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0035-2023", "product_description": "LIDOCAINE/PHENYLEPHRINE PF SYR 1%/1.5% Solution, 3 mL syringes, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "389 syringes", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lot: 65972, BUD: 10/27/2022"}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90992", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "N/A", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-0011-2023", "product_description": "Rifampin Capsules, USP, 300 mg, packaged in a) 30-count bottle (NDC 51407-323-30), b) 60-count bottle (NDC 51407-323-60), c) 100-count bottle (NDC 51407-323-01), Rx only, Manufactured by Patheon Pharmaceuticals Inc., OH, Packaged by GSMS, Incorporated, CA.", "product_quantity": "N/A", "reason_for_recall": "Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).", "recall_initiation_date": "20221006", "center_classification_date": "20221017", "termination_date": "20250319", "report_date": "20221026", "code_info": "Lot#: a) GS041430, GS041941, Exp 1/31/2023; GS041315, GS042991, GS043027, GS043367, GS043501, GS044421, Exp 3/31/2023; b) GS041431, GS041799, GS042287, GS042414, GS042879, Exp: 1/31/2023; GS041316, GS042992, GS043368, GS043579, Exp 3/31/2023; c) GS041429, GS041877, Exp 1/31/2023; GS041317, GS043028, GS043366, GS044422, Exp 3/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA087242"], "brand_name": ["AMINOPHYLLINE"], "generic_name": ["AMINOPHYLLINE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-5921", "0409-5922"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["AMINOPHYLLINE DIHYDRATE"], "rxcui": ["1724666", "1724668"], "spl_id": ["656c6018-d716-452b-99cc-cde5360f73e6"], "spl_set_id": ["9a663ef3-881f-48bd-2689-3713b24545c2"], "package_ndc": ["0409-5921-16", "0409-5921-01", "0409-5922-16", "0409-5922-01"], "is_original_packager": [true], "unii": ["C229N9DX94"]}, "product_type": "Drugs", "event_id": "90903", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed in the United States and Puerto Rico.", "recall_number": "D-0003-2023", "product_description": "Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) 25x10 mL Single-dose vial, Rx only,  Distributed by Hospira, Inc. Lake Forest, IL 60045 USA. NDC 0409-5921-16 (vial) 0409-5921-01 (carton)", "product_quantity": "103,150 10 mL vials", "reason_for_recall": "Presence of Particulate Matter: A complaint was received for the presence of a hair in one vial.", "recall_initiation_date": "20220927", "center_classification_date": "20221004", "termination_date": "20240821", "report_date": "20221012", "code_info": "Lot: 30-137-DK Exp. 1 DEC. 2022"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0039-2023", "product_description": "MITOMYCIN INJECTION 0.375 mg/mL SYR, 0.375 mg/mL solution, 1 mL syringe, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "185 syringes", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lots: 60618, BUD: 5/6/2023; 66536, BUD: 7/8/2023"}, {"status": "Terminated", "city": "Pacific Palisades", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA213312"], "brand_name": ["FYARRO"], "generic_name": ["SIROLIMUS"], "manufacturer_name": ["Aadi Bioscience"], "product_ndc": ["80803-153"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SIROLIMUS"], "rxcui": ["2586863", "2586868"], "spl_id": ["5cc321b2-bc32-443d-b334-8b8752a673c5"], "spl_set_id": ["0f9bb784-53e2-46f9-a65d-1c6c2a230eaf"], "package_ndc": ["80803-153-50"], "is_original_packager": [true], "nui": ["N0000175550", "N0000175625", "N0000175624", "N0000175605", "N0000175076"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "pharm_class_epc": ["mTOR Inhibitor Immunosuppressant [EPC]", "Kinase Inhibitor [EPC]"], "pharm_class_moa": ["mTOR Inhibitors [MoA]", "Protein Kinase Inhibitors [MoA]"], "unii": ["W36ZG6FT64"]}, "product_type": "Drugs", "event_id": "91019", "recalling_firm": "Aadi Bioscience", "address_1": "17383 W Sunset Blvd Ste A250", "address_2": "N/A", "postal_code": "90272-4181", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Within the U.S Market - PA, AL, KY, TN", "recall_number": "D-0059-2023", "product_description": "Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound), 100 mg per vial, NDC 80803-153-50, manufactured for Aadi Bioscience, Inc, CA.", "product_quantity": "2,333 vials", "reason_for_recall": "Failed Stability Specifications", "recall_initiation_date": "20221013", "center_classification_date": "20221114", "termination_date": "20230316", "report_date": "20221123", "code_info": "Lot# 6025701, Expiration Date: 31MAR2023, 100mg/vial, 50 ml single use vial, NDC 80803-153-50."}]